Beyond Call Centers and Towards Infinite Engagement

Part 1 of Our Series: Reimagining Patient Services with Conversational AI

Conversational AI enables pharmaceutical companies to streamline high-volume patient
services, reduce friction at critical access points, and deliver consistent, on-demand
support to patients. The result is a more efficient, scalable model that not only lowers
operational burden but also strengthens engagement, helping patients start and stay on
therapy with greater confidence.

As the healthcare landscape continues to rapidly evolve, patient services departments at
pharmaceutical companies are often the unsung heroes of patient support. Traditionally,
these departments have operated as glorified call centers, connecting patients with
resources, answering inquiries, and managing a multitude of tasks associated with therapy
initiation and adherence. However, the sheer scale and complexity of these operations
come with inherent limitations—high operational costs, long response times, and varying
levels of patient satisfaction.

Enter conversational AI: a game-changer for patient services. At its core, conversational AI
leverages advanced digital agent technology to automate and optimize the work
traditionally handled by hub agents. The implications? A leaner, more efficient operation
and an unparalleled opportunity to transform the patient experience.

How can Phluence™
help you?

Vestibulum et tortor ornare dolor sollicitudin lobortis. Nam imperdiet, erat quis lobortis dictum, mauris elit aliquet mi, quis sodales diam odio eget tellus. Suspendisse fringilla rutrum enim vitae elementum. Nam imperdiet, erat quis lobortis dictum.
*Required fields

Please read our Privacy Policy to see how we use your personal information.

Automating the Core of Patient Services

  • Conversational AI can seamlessly take over many of the high-volume, repetitive tasks
    handled by patient services hubs, allowing human agents to focus on more complex and
    nuanced patient needs. Here are some of the critical use cases where AI is making a
    measurable impact:

    Program Education & FAQs: Patients often call for basic information about
    programs or therapies. AI-driven digital agents can deliver instant, consistent
    responses, ensuring that patients always have access to accurate information.
  • Program Enrollment & Onboarding: Simplifying enrollment processes with AI
    reduces friction for patients and shortens the time to therapy initiation. Onboarding
    is enhanced with step-by-step guidance, ensuring patients feel supported from the
    start.
  • Status Updates & Shipment Tracking: Conversational AI provides patients with
    real-time updates and tracking information without wait times.
  • Specialty Pharmacy (SP) Referrals: Automating SP referral workflows ensures
    quicker connections between patients and the pharmacies they need, further
    accelerating access to therapy

By automating these touchpoints, conversational AI drives both top-line revenue growth
and bottom-line cost efficiencies:

  • Top-Line Revenue Growth: Faster onboarding and improved communication
    enhance first-fill rates and ensure patients stay on therapy longer, leading to better
    health outcomes and increased revenue.
  • Bottom-Line Cost Reduction: Reduced call attempts, higher connection rates, and
    automation of routine processes slash operational costs while simultaneously
    improving the overall patient experience.

Beyond Replacement: Reimagining Patient Engagement

While replacing existing touchpoints with AI offers significant ROI, this perspective is short-
sighted. The true potential of conversational AI lies not just in replacing what exists, but in
redefining what’s possible.

Imagine a world where the cost to engage patients is no longer a limiting factor.
Conversational AI creates opportunities to introduce new touchpoints, engaging patients
more frequently and meaningfully at a fraction of the traditional cost. With this infinite
scalability, pharma companies can ask a transformative question:

If you had unlimited resources to engage patients, how would you reimagine the patient
experience?

The possibilities are endless:

  • Proactive Engagement: Digital agents could check in with patients to ensure they
    understand their therapy regimen or remind them of upcoming milestones.
  • Dynamic Personalization: AI can adapt its interactions based on individual patient
    needs, delivering hyper-personalized support that evolves over time.
  • Continuous Monitoring: Conversational AI can collect valuable data during every
    interaction, enabling companies to identify trends and intervene earlier in cases of
    non-adherence or therapy dropout.

The Infinite Engagement Era

Patient services departments are no longer bound by the constraints of traditional models. Conversational AI opens the door to an infinite engagement strategy, where the cost of adding more touchpoints is negligible, and every patient interaction is an opportunity to create value. Pharma companies that embrace this shift will not only optimize their operations but also redefine patient support. By leveraging conversational AI to automate what’s possible and imagine what’s not yet been done, they can transform patient services into a key driver of business success and better patient outcomes. The future of patient services isn’t just more efficient—it’s limitless. The question is: Are you ready to reimagine it?

Related Articles

Part 1 of Our AFP Intelligence Series: The Hidden Threat to Specialty Brand Revenue &...

April 23, 2026

Part 2 of Our AFP Intelligence Series: The Hidden Threat to Specialty Brand Revenue &...

April 23, 2026

Part 3 of Our AFP Intelligence Series: The Hidden Threat to Specialty Brand Revenue &...

April 23, 2026

The Emerging Prerequisite to Drug Affordability: Digital Patient Engagement Drug affordability is one of the...

April 21, 2026

Part 2 of Our Series: Reimagining Patient Services with Conversational AI What does “infinite engagement”...

April 21, 2026

Part 4 of Our AFP Intelligence Series: The Hidden Threat to Specialty Brand Revenue &...

April 21, 2026